Related Experiment Video
Updated: Apr 8, 2026
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Using Xenopus to discover new genes involved in branchiootorenal spectrum disorders
Sally A Moody1, Karen M Neilson1, Kristy L Kenyon2
1Department of Anatomy and Regenerative Biology, George Washington University, School of Medicine and Health Sciences, Washington, DC, USA.
Insights
Researchers identified new genes linked to congenital hearing loss and kidney defects using Xenopus laevis. This discovery aids in early diagnosis and understanding of Branchiootorenal spectrum disorders.
Area of Science:
- Genetics
- Developmental Biology
- Otolaryngology
Background:
- Congenital hearing loss impacts language and social development in children.
- Early diagnosis through prenatal genetic screening is crucial for intervention.
- Branchiootorenal spectrum disorders involve hearing deficits and potential kidney defects.
Purpose of the Study:
- To identify novel candidate genes associated with Branchiootorenal spectrum disorders.
- To investigate the developmental genetic pathway of Six1 in otic and kidney development.
- To explore the utility of Xenopus laevis as a model for human congenital hearing loss gene discovery.
Main Methods:
- Utilized Xenopus laevis as an aquatic animal model.
- Focused on identifying Six1 transcriptional targets and co-factor proteins.
- Analyzed gene expression patterns during otic and kidney development.
Main Results:
- Identified numerous potential Six1 transcriptional targets.
- Discovered candidate co-factor proteins interacting with Six1.
- Confirmed expression of identified genes in relevant developmental tissues and times.
Conclusions:
- Xenopus laevis is a valuable model for discovering genes involved in congenital hearing loss syndromes.
- The identified genes and proteins are crucial for understanding Branchiootorenal spectrum disorders.
- Further research can leverage these findings for improved diagnostics and therapeutics.
Abstract:
Congenital hearing loss is an important clinical problem because, without early intervention, affected children do not properly acquire language and consequently have difficulties developing social skills. Although most newborns in the US are screened for hearing deficits, even earlier diagnosis can be made with prenatal genetic screening. Genetic screening that identifies the relevant mutated gene can also warn about potential congenital defects in organs not related to hearing. We will discuss efforts to identify new candidate genes that underlie the Branchiootorenal spectrum disorders in which affected children have hearing deficits and are also at risk for kidney defects. Mutations in two genes, SIX1 and EYA1, have been identified in about half of the patients tested. To uncover new candidate genes, we have used the aquatic animal model, Xenopus laevis, to identify genes that are part of the developmental genetic pathway of Six1 during otic and kidney development. We have already identified a large number of potential Six1 transcriptional targets and candidate co-factor proteins that are expressed at the right time and in the correct tissues to interact with Six1 during development. We discuss the advantages of using this system for gene discovery in a human congenital hearing loss syndrome.
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
01:33Pleiotropy